ResearcherUniversity of MiamiNo recent work listed
Anthony R. Ferrantella
Matched on ORCID iD 0000-0003-3252-4821; OpenAlex author ID A5010383900. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2019: 2 papers · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper
Papers 6
- Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from "first contact" interactions in the tumor microenvironment. Co-author DOI 10.1186/s13046-022-02425-y↗
- An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. First author DOI 10.1007/s11605-020-04681-9↗
- Hsp70 modulates immune response in pancreatic cancer through dendritic cells. Co-author DOI 10.1080/2162402x.2021.1976952↗
- Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. Co-author DOI 10.1172/jci127515↗
- Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression,remodels extracellular matrix and sensitizes to anti-PD1 therapy Co-author DOI 10.1016/j.pan.2019.05.430↗
- Radiotherapy as an Adjunct to Surgery for Pancreatic Cancer: Where Are We After More Than 30 Years of Research and Trials? Co-author DOI 10.1245/s10434-019-07787-w↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Vikas Dudeja · 5 shared papers, 2019–2021 · strength 0.57
- Paper Radiotherapy as an Adjunct to Surgery for Pancreatic Cancer: Where Are We After More Than 30 Years of Research and Tria… DOI 10.1245/s10434-019-07787-w↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. DOI 10.1172/jci127515↗
- Ashok Kumar Saluja · 5 shared papers, 2019–2022 · strength 0.53
- Paper Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from "first contact" interactions in the tum… DOI 10.1186/s13046-022-02425-y↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. DOI 10.1172/jci127515↗
- Bhuwan Giri · 4 shared papers, 2019–2021 · strength 0.41
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. DOI 10.1172/jci127515↗
- Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
- Harrys K.C. Jacob · 3 shared papers, 2021–2022 · strength 0.34
- Paper Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from "first contact" interactions in the tum… DOI 10.1186/s13046-022-02425-y↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Hsp70 modulates immune response in pancreatic cancer through dendritic cells. DOI 10.1080/2162402x.2021.1976952↗
- Sulagna Banerjee · 3 shared papers, 2019–2021 · strength 0.31
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy. DOI 10.1172/jci127515↗
- Paper Targeting tumor intrinsic metabolic node in pancreatic cancer causes tumor regression,remodels extracellular matrix and… DOI 10.1016/j.pan.2019.05.430↗
- Sundaram Ramakrishnan · 2 shared papers, 2021 · strength 0.22
- Vrishketan Sethi · 2 shared papers, 2021 · strength 0.22
- Tejeshwar Jain · 2 shared papers, 2021 · strength 0.22
- Prateek Sharma · 2 shared papers, 2021 · strength 0.22
- Kousik Kesh · 2 shared papers, 2019–2020 · strength 0.19
- Vineet Kumar Gupta · 2 shared papers, 2019–2020 · strength 0.19
- Nikita Sharma · 2 shared papers, 2019–2020 · strength 0.19
- Chandrakanth Are · 1 shared paper, 2019 · strength 0.16
- Ashley Nicole Middleton · 1 shared paper, 2022 · strength 0.12
- Haleh Amirian · 1 shared paper, 2022 · strength 0.12
- Shweta Lavania · 1 shared paper, 2022 · strength 0.12
- Shrey Modi · 1 shared paper, 2021 · strength 0.11
- Nipun B. Merchant · 1 shared paper, 2021 · strength 0.11
- Zoe X. Malchiodi · 1 shared paper, 2021 · strength 0.10
- Bharti Garg · 1 shared paper, 2021 · strength 0.10
- Utpreksha Vaish · 1 shared paper, 2021 · strength 0.10
- Siddharth Mehra · 1 shared paper, 2021 · strength 0.10
- Srikanth Iyer · 1 shared paper, 2021 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.